ArticleAsia-Pacific journal of clinical oncology2020

Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study.

Zhichao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.